Drug Type Small molecule drug |
Synonyms F 0930, F 0930RS, F-0930 + [2] |
Target |
Action antagonists |
Mechanism 5-HT3 receptor antagonists(Serotonin 3 (5-HT3) receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H20N4 |
InChIKeyPWWDCRQZITYKDV-UHFFFAOYSA-N |
CAS Registry143257-98-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Lerisetron | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Seminoma | Phase 3 | - | 09 Aug 2004 | |
Testicular Germ Cell Tumor | Phase 3 | - | 09 Aug 2004 | |
Vomiting | Phase 3 | - | 09 Aug 2004 | |
Nausea | Phase 3 | - | 09 Aug 2004 | |
Nausea and vomiting | Phase 3 | - | 09 Aug 2004 |